News & Updates
Filter by Specialty:
Immune-related AEs tied to improved survival in bladder cancer patients on atezolizumab
In patients with locally advanced or metastatic urothelial cancer patients receiving atezolizumab treatment, immune-related adverse events (AEs) were associated with improved survival outcomes, according to an analysis of individual participant data from the IMvigor210 and IMvigor211 studies.
Immune-related AEs tied to improved survival in bladder cancer patients on atezolizumab
27 Apr 2023
EAGLE trials herald new era for uncomplicated UTI treatment
Oral gepotidacin, an investigational, first-in-class oral antibiotic with a novel mechanism of action, showed favourable signals for the treatment of uncomplicated urinary tract infections (uUTIs), according to the results of two phase III trials.
EAGLE trials herald new era for uncomplicated UTI treatment
25 Apr 2023
Maximal transurethral resection tied to better outcomes at cystectomy
Pathological response at cystectomy may improve with maximal resection in patients undergoing transurethral resection for muscle-invasive bladder cancer prior to neoadjuvant chemotherapy, according to a study.
Maximal transurethral resection tied to better outcomes at cystectomy
19 Apr 2023
MV-140 vaccine proven safe, effective in recurrent UTI
Immunotherapy with MV-140 (Uromune) successfully prevents urinary tract infections (UTIs) in patients suffering from recurrent UTIs, suggest the results of a prospective study presented at the 38th Annual EAU Congress (EAU 2023).
